Provider review
Lemonaid Health review
Microdose-forward tracks for both molecules, with the visit billed apart.
The advertised figures cover medication; the provider visit is billed separately, so the total stacks.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated June 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
$199/mo (med separate)
Visit Lemonaid HealthPrice as published
Lemonaid Health
$199/mo (med separate)
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Prices the low dose on its own
- Dispensed
- Compounded, an unnamed partner network
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Both drugs have a microdose-forward track here, on an established telehealth platform, with a brand-referral pathway where appropriate — a reasonable place to start low if platform maturity matters to you. The number to watch is the total rather than the headline: the advertised figures cover the medication and the provider visit is billed separately on this platform, so the real monthly cost stacks. There is no included registered-dietitian support, and the compounded line carries the same post-shortage regulatory and sourcing exposure as the other providers here.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want an established telehealth platform rather than a new operator
- You want a low-dose track for either molecule
- You want a brand referral available if compounded is not the right route
Look elsewhere if
- You are comparing on all-in cost — the visit is billed apart from the medication
- You want dietitian support included
- You want distance from post-shortage compounded sourcing risk
What it actually costs
Price as published
$199/mo (med separate)
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Prices the low dose on its own
Publishes a price for a microdose track, but no standard-dose price alongside it — so you can cost the low dose, you just cannot see what it saves you.
23 of the 407 programs here price a small dose this way. Publishes microdose tracks for both molecules at their own rate, with no standard-dose price alongside to compare against, and the visit billed separately.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Optional
- Pricing
- Varies by dose, plan or tier
What it does well
- Microdose-forward tracks for both semaglutide and tirzepatide
- Established telehealth platform with provider visits and a brand-referral pathway
Pharmacy, labs and oversight
Lemonaid Health says it uses an unnamed partner network, but does not say which one. Bloodwork is offered but not required. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Lemonaid Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedSays it uses an unnamed partner network, but does not say which one.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Provider visit on Lemonaid's telehealth platform, then compounded semaglutide or tirzepatide in a microdose track, with brand referral where appropriate. The advertised $199/mo figures cover the medication; the provider visit is billed separately from the medication on this platform.
The honest cons
Medication is billed separately from the visit — total cost stacks
- Compounded GLP-1s carry post-shortage regulatory and sourcing exposure
- No included registered-dietitian support
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Lemonaid Health is one of 407 low-dose GLP-1 programs compared on this site, and 261 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs to compare with Lemonaid Health. Both are partners: we may earn a commission if you start care through these links.
Partner
yourEra
$179/mo microdose
Prices the low dose on its own
Partner
Strut Health
$99/mo sema lozenge (auto-refill)
Standard plan, self-directed low dose
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
Where this sits
#35 of 407
Ordered with the companies that pay us first, and Lemonaid Health is not one of them. A disclosed partition, not a score.
Compare all 407 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- Microdosing semaglutide
- Microdosing tirzepatide
- What the evidence actually shows
- Microdose & reconstitution calculator
- Titration planner
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
CoreAge Rx
$149–$199/mo microdose ($99–$149 standard)
- Vs median
- $20/mo below the $169 median
- Market
- $59–$1,300/mo across 261 of 407
- Structure
- Prices the low dose on its own
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the CoreAge Rx review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.